| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $16.1M | -55.7% |
| SG&A Expense | $18.7M | -8.5% |
| Operating Income | -$39.8M | +28.9% |
| Interest Expense | $3.1M | +14.3% |
| Net Income | -$42.3M | +7.2% |
| EPS (Basic) | -$10.15 | -2643.2% |
| EPS (Diluted) | -$10.15 | +9.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.0M | -32.0% |
| Short-term Investments | $42.2M | -41.9% |
| Current Assets | $60.2M | -39.9% |
| Total Assets | $66.3M | -38.4% |
| Current Liabilities | $12.6M | -25.7% |
| Long-term Debt | $21.6M | +1.9% |
| Total Liabilities | $33.3M | -13.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.5M | +22.1% |
| Capital Expenditures | $13K | -75.2% |
| Investing Cash Flow | $30.1M | +141.0% |
| Financing Cash Flow | -$534K | -100.9% |
| Free Cash Flow | -$37.6M | +22.1% |
| Stockholders' Equity |
| $33.0M |
| -52.3% |